CABS 2021 INVESTOR FORUM
Joint Fight Against COVID-19, Viva Biotech Contributes to the Production of the Oral COVID-19 Antiviral Medication and Virus Tests
Haya Therapeutics shouts 'hiya!' as it emerges from stealth with seed funding
News Viva BioInnovator
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs, Business News - AsiaOne
Viva BioInnovator YOUR PARTNER FOR SUCCESS
Viva BioInnovator YOUR PARTNER FOR SUCCESS
Healthcare Weekly Pulse Check Issue #1 Jan.1-Jan.7, 2022
Viva Biotech Announced 2022 Annual Results
Viva Biotech Successfully Held The 3rd Annual Partnership Summit
Riparian Pharmaceuticals inks license and research agreement with Pfizer for cardiovascular programs
News Viva BioInnovator
About Us Viva BioInnovator
The Dos & Don'ts of Fundraising: Insights from Viva BioInnovator
Viva Biotech Successfully Held The 3rd Annual Partnership Summit